Rebecca Chambers “I am honored to be a part of Outset at this time in its growth trajectory. San Jose, CA 95134. * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). Rebecca Chambers Chief Financial Officer Rebecca brings to Outset Medical a wealth of experience in finance including investor relations, treasury, and financial planning and analysis. She has a wealth of experience across finance functions including investor relations, treasury, and financial planning and analysis. “We recognized in Rebecca a best-in-class ability to build a strong financial foundation and effective, transparent relationships with the investment community. Dr. Monica Bertagnolli is currently Professor of Surgery at Harvard Medical School and Associate Surgeon in the Division of Surgical Oncology at Brigham and Women's Hospital and Dana-Farber Cancer Institute. Rebecca Chambers has been appointed Chief Financial Officer of Outset Medical. Yamamoto brings nearly 20 years of experience in mergers & acquisitions and business development. "Altogether, these additions to our team are important to ensure continued expansion and the ability to deliver on the ambitious goals set forth by the Board and owners of UNION, with the overarching vision of advancing medicine by listening and responding to patient needs." Contact us: firstname.lastname@example.org, Learn how Medical Device News Magazine can help promote your medical devices. Dillon is a former St. Jude Medical and Abiomed executive, with significant experience capitalizing and commercializing first-in-class heart failure and cardiorenal syndrome technologies. Outset Medical is a commercial-stage company that delivers state-of-the-art technology to the growing global dialysis market. Former Illumina Executive Rebecca Chambers Joins Outset as Company Scales to Meet Demand. In addition, she held roles of increasing responsibility at companies including Myriad Genetics, Life Technologies, Bank of America Merrill Lynch, and Millennium Pharmaceuticals. Feldman will be responsible for forging and maintaining relationships with pharmaceutical manufacturers to coincide with Soleo Health’s expertise and focus on caring for complex specialty patients with rare and ultra-rare diseases. Rebecca joined the company from Illumina where she most recently served as Vice President of Finance. Rebecca brings to Outset Medical a wealth of experience in finance including investor relations, treasury, and financial planning and analysis. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. He will serve as Director, Science & Innovation, and will lead the Telos scientific services to lay the foundations of evidence necessary to meet medical device and biotechnology commercialization objectives.
Over the course of her career at Illumina, Rebecca Chambers led numerous financial functions including treasury, clinical financial planning and analysis and investor relations (IR). Neil will lead operations, sales, marketing and product development of the Monitoring Solution Division. November 23, 2020 Lifecare AS announced it has enhanced its Board of Directors (BOD) after an extraordinary general meeting Friday 20 November 2020. VectivBio Chief Executive Officer Luca Santarelli, MD said, "We are truly fortunate to have Sarah and Aditya on our team. Gordon has 20 years of experience in the life science tools market and has held senior positions at ForteBio, Phasefocus, and Unchained Labs. Previously, she held roles of increasing responsibility at companies including Myriad Genetics, Life Technologies, Bank of America Merrill Lynch, and Millennium Pharmaceuticals. She joins the company from Illumina where she was most recently the Vice President of Finance. This announcement follows the recent closing of a financing round led by Eir Ventures and Vaekstfonden. Wireless data, sensor-based automati. Rebecca Chambers has been named chief financial officer at Outset Medical , according to a press release.